BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8457265)

  • 1. Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.
    Makino K; Josephson MA; Fellner SK; Scanu AM
    Atherosclerosis; 1993 Jan; 98(2):255-6. PubMed ID: 8457265
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis are not related to peritoneal losses of albumin.
    Montenegro J; Moina I; Saracho R; González O; Martínez I; Esteban M
    Nephron; 1997; 76(2):239-41. PubMed ID: 9200424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma carnitine levels in patients undergoing hemodialysis.
    Reddi AS; Moquete M; Keshav G; DeAngelis B; Frank O; Baker H
    Nephron; 1998 Sep; 80(1):87-8. PubMed ID: 9730713
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.
    Romero RA; Salgado O; Rodríguez-Iturbe B; Tahán JE
    Transplant Proc; 1996 Dec; 28(6):3382-4. PubMed ID: 8962320
    [No Abstract]   [Full Text] [Related]  

  • 6. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
    Finkelstein FO; Smith JD
    ASAIO J; 1996; 42(1):1-3. PubMed ID: 8808447
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin?
    Mehrotra R; Kalantar-Zadeh K; Adler S
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1520-2. PubMed ID: 21734081
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'angelo A; Maffioli P
    Cytokine; 2017 Apr; 92():75-79. PubMed ID: 28110120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 and type 2 diabetes and renal replacement therapy.
    Catalano C; Biondi B; Fabrizi F
    Diabet Med; 1989; 6(1):86. PubMed ID: 2522382
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney-pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Transplant Proc; 1994 Apr; 26(2):500. PubMed ID: 8171524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of opiate receptor blockade with naloxone on prolactin (PRL) secretion in patients with diabetes type I (IDDM) with chronic renal failure treated with hemodialysis (HD)].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Gumprecht J; Liszka M; Snit M; Gawron J
    Pol Arch Med Wewn; 1996 Aug; 96(2):132-42. PubMed ID: 9122001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum TSH levels and negative TRH test in dialysis patients.
    Evers J; Scheid H
    Nephron; 1995; 71(3):357-8. PubMed ID: 8569987
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement in nutritional parameters after initiation of chronic hemodialysis.
    Pupim LB; Kent P; Caglar K; Shyr Y; Hakim RM; Ikizler TA
    Am J Kidney Dis; 2002 Jul; 40(1):143-51. PubMed ID: 12087572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal failure and management of diabetes.
    Bilous RW
    Diabet Med; 2004 Jan; 21 Suppl 1():12-4. PubMed ID: 15088931
    [No Abstract]   [Full Text] [Related]  

  • 16. Future trends of management of renal failure in diabetics.
    Cordonnier D; Bayle F; Benhamou PY; Milongo R; Zaoui P; Maynard C; Halimi S
    Kidney Int Suppl; 1993 Jun; 41():S8-13. PubMed ID: 8320952
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialyzing the diabetic - a second look.
    Roxe DM
    Int J Artif Organs; 1982 Sep; 5(5):284-6. PubMed ID: 6757148
    [No Abstract]   [Full Text] [Related]  

  • 18. High lipoprotein(a) levels in type 1 and type 2 diabetic patients with macroalbuminuria.
    Relimpio F; Acosta D; Losada F; Pumar A; Serrera JL; Mangas MA; Astorga R
    Diabetes Care; 1997 Dec; 20(12):1921-2. PubMed ID: 9405921
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study.
    Dewitte K; Dhondt A; Giri M; Stöckl D; Rottiers R; Lameire N; Thienpont LM
    Diabetes Care; 2004 Oct; 27(10):2503-5. PubMed ID: 15451927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R; Gómez M; Olea C
    Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.